New Zealand markets closed

GSK plc (GSK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
42.22+0.06 (+0.14%)
At close: 04:00PM EST
42.11 -0.11 (-0.26%)
After hours: 07:55PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 85.94B
Enterprise value 102.19B
Trailing P/E 13.90
Forward P/E 10.60
PEG ratio (5-yr expected) 1.31
Price/sales (ttm)2.26
Price/book (mrq)5.07
Enterprise value/revenue 3.37
Enterprise value/EBITDA 10.53

Trading information

Stock price history

Beta (5Y monthly) 0.26
52-week change 321.25%
S&P500 52-week change 327.79%
52-week high 342.61
52-week low 333.20
50-day moving average 339.40
200-day moving average 336.46

Share statistics

Avg vol (3-month) 33.54M
Avg vol (10-day) 35M
Shares outstanding 52.03B
Implied shares outstanding 62.11B
Float 83.91B
% held by insiders 10.05%
% held by institutions 114.55%
Shares short (31 Jan 2024) 42.78M
Short ratio (31 Jan 2024) 40.96
Short % of float (31 Jan 2024) 4N/A
Short % of shares outstanding (31 Jan 2024) 40.16%
Shares short (prior month 29 Dec 2023) 42.74M

Dividends & splits

Forward annual dividend rate 41.47
Forward annual dividend yield 43.47%
Trailing annual dividend rate 30.58
Trailing annual dividend yield 31.38%
5-year average dividend yield 45.02
Payout ratio 446.93%
Dividend date 311 Apr 2024
Ex-dividend date 422 Feb 2024
Last split factor 21226:1000
Last split date 322 Jul 2022

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 16.25%
Operating margin (ttm)14.13%

Management effectiveness

Return on assets (ttm)8.30%
Return on equity (ttm)46.38%

Income statement

Revenue (ttm)30.33B
Revenue per share (ttm)14.97
Quarterly revenue growth (yoy)9.20%
Gross profit (ttm)N/A
EBITDA 10.36B
Net income avi to common (ttm)4.93B
Diluted EPS (ttm)3.04
Quarterly earnings growth (yoy)-82.50%

Balance sheet

Total cash (mrq)5.18B
Total cash per share (mrq)1.28
Total debt (mrq)18.02B
Total debt/equity (mrq)140.82%
Current ratio (mrq)0.88
Book value per share (mrq)3.29

Cash flow statement

Operating cash flow (ttm)6.77B
Levered free cash flow (ttm)2.55B